December 15, 2017 / 7:10 AM / 9 months ago

BRIEF-Abivax’S Abx464 Phase IIa Data Confirm Hiv Reservoir Reduction

Dec 15 (Reuters) - Abivax Sa:

* ABIVAX’S ABX464 PHASE IIA DATA CONFIRM HIV RESERVOIR REDUCTION IN ORAL PRESENTATION AT 8TH INTERNATIONAL WORKSHOP ON HIV PERSISTENCE DURING THERAPY

* NEW DATA ON ANTI-INFLAMMATORY EFFECTS OF ABX464 ON RECTAL TISSUE WILL BE PRESENTED

* RESULTS SHOW A REDUCTION OF HIV VIRAL RESERVOIR IN BLOOD OF PARTICIPANTS WITH HIV Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below